Form 4: Health Catalyst Director, Duncan Gallagher, Reports Acquisition of 3,033 Shares of Common Stock

Director Duncan Gallagher reports acquiring 3,033 shares of Health Catalyst, Inc. common stock through vested restricted stock units.

Summary

• On March 1, 2025, Duncan Gallagher, a director of Health Catalyst, Inc., acquired 3,033 shares of common stock.
• The acquisition was through the vesting of restricted stock units (RSUs) granted under the company's 2019 Stock Option and Incentive Plan.
• Each RSU represents a contingent right to receive one share of Health Catalyst's common stock.
• 100% of the RSUs vested on March 1, 2025, in accordance with the terms of the Issuer's Non-Employee Director Compensation Policy.
• Following the transaction, Gallagher directly owns 72,971 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.

Positives

• The vesting of RSUs aligns the director's interests with those of the shareholders.
• The director's increased stake in the company could be seen as a sign of confidence in Health Catalyst's future prospects.

Industry Context

This transaction is a routine part of executive compensation and equity ownership, common in publicly traded companies to align management and board member interests with shareholder value.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates